Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Epstein

Showing results (11-20 of 1,864) with videos related to

Pageof 187
Sort By:
Heart Disease (Hagerstown, Md.)|April 27, 2002
Lercanidipine: a novel dihydropyridine calcium-channel blockerM Epstein
Circulation Research|November 1, 1976
Cardiovascular and renal effects of head-out water immersion in man: application of the model in the assessment of volume homeostasisM Epstein
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
Diabetes and hypertension: the bad companionsM Epstein
Blood Pressure. Supplement|January 1, 1994
Hypertension as a risk factor for progression of chronic renal diseaseM Epstein
The American Journal of Cardiology|May 22, 1997
The calcium antagonist controversy: the emerging importance of drug formulation as a determinant of riskM Epstein
Gastroenterology|December 1, 1985
Derangements of renal water handling in liver diseaseM Epstein
American Journal of Nephrology|January 1, 1989
Atrial natriuretic factor in patients with liver diseaseM Epstein
American Family Physician|April 1, 1985
Aging and the kidney: clinical implicationsM Epstein
Nephron|January 1, 1979
Renal sodium handling in cirrhosis: a reappraisalM Epstein
Soins. Psychiatrie|December 1, 1985
[Pierre Janet, promoter of clinical psychology. Memories...]M Epstein
Pageof 187

Showing results (11-20 of 1,864) with videos related to

Sort By:
Pageof 187
Heart Disease (Hagerstown, Md.)|April 27, 2002
Lercanidipine: a novel dihydropyridine calcium-channel blockerM Epstein
Circulation Research|November 1, 1976
Cardiovascular and renal effects of head-out water immersion in man: application of the model in the assessment of volume homeostasisM Epstein
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
Diabetes and hypertension: the bad companionsM Epstein
Blood Pressure. Supplement|January 1, 1994
Hypertension as a risk factor for progression of chronic renal diseaseM Epstein
The American Journal of Cardiology|May 22, 1997
The calcium antagonist controversy: the emerging importance of drug formulation as a determinant of riskM Epstein
Gastroenterology|December 1, 1985
Derangements of renal water handling in liver diseaseM Epstein
American Journal of Nephrology|January 1, 1989
Atrial natriuretic factor in patients with liver diseaseM Epstein
American Family Physician|April 1, 1985
Aging and the kidney: clinical implicationsM Epstein
Nephron|January 1, 1979
Renal sodium handling in cirrhosis: a reappraisalM Epstein
Soins. Psychiatrie|December 1, 1985
[Pierre Janet, promoter of clinical psychology. Memories...]M Epstein
Pageof 187